Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRPL30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRTG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLYBL-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANKRD50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ID4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREBL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UMPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALOX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00308 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on